Vinge advised Vimian Group AB on the offering. Vimian Group AB (publ) partly guaranteed rights issue which will provide Vimian with issue proceeds of SEK 1,633...
Vimian Group’s Rights Offering
Norvestor’s Public Offering for Permascand
Vinge advised Norvestor on the deal. Norvestor VI L.P received a public offer by Altor PC AB to the shareholders of Permascand Top Holding AB (publ). Norvestor holds...
Thermo Fisher’s Acquisition of Olink
Vinge and Cravath Swaine & Moore advised Thermo Fisher Scientific Inc. on the deal, Ropes & Gray advised Summa Equity AB, Baker McKenzie advised Olink, Debevoise...
EQT IX’s Sale of Shares in Beijer Ref AB
Vinge advised EQT IX on the deal. EQT IX completed the sale of shares in Beijer Ref AB (publ) through an accelerated bookbuilding. In total, 40...
Symrise’s Mandatory Bid for Swedencare
Vinge advised Symrise on the deal. Symrise AG has made a public mandatory bid for all shares in Swedencare AB (publ). The offer values all shares in...
Xspray Pharma’s SEK 300 Million Rights Issuance
Vinge acted for Xspray Pharma in connection with its rights issue of units. Through the rights issue of units, Xspray (STO:XSPRAY) is expected to receive approximately SEK 300...
François-Charles Oberthur’s SEK 189 Million Public Offer for Rolling Optics
Vinge advised François-Charles Oberthur on the deal, while Delphi advised Rolling Optics. François-Charles Oberthur SAS announced a cash offer to the holders of ordinary shares, preference shares,...
Oncopeptides’ €30 Million Loan Agreement With European Investment Bank
Vinge has advised Oncopeptides on the deal. Wigge & Partners advised the European Investment Bank (EIB). The loan agreement with the European Investment Bank (EIB) grants...
Vimian’s SEK 1,500 Million Directed Share Issue
Vinge advised Vimian on the deal. Vimian completed a directed share issue of approximately MSEK 1,500, before issue costs. The share issue is in part based on...
Oncopeptides’ SEK 435,6 Million Directed Share Issue
Vinge advised Oncopeptides on the deal. The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncopeptides will raise proceeds...
MGM’s $607 Million Public Offer For LeoVegas
Vinge and Weil, Gotshal & Manges advised MGM on the deal. Cederquist advised the Board of Directors of LeoVegas. Gernandt & Danielsson advised LeoVegas’ founders and...
EQT AB’s €1.5 Billion Bonds Issue
Vinge, together with Latham & Watkins, advised EQT AB. EQT AB (publ) has completed the issuance of a EUR 750,000,000 sustainability-linked bond maturing in 2028 and...